Please note this module may not run if we do not achieve a minimum threshold of students. Hence students who apply for this module as part of the programme pathway for year 1 entry may be required to select a second optional module as their reserve.
This module provides an introduction to the detection and screening for cancers and awareness of national and local policies related to cancer treatment, common therapies and regimens used and the management of side effects associated with treatment, holistic medicines optimisation for cancer patients and supportive services for patients and families. Case studies reflecting practice across sectors will be used.
This module provides students with an understanding of the management of pre-diagnosed and cancer patients based on integrated care systems principles, thereby enabling practitioners to demonstrate the principles of evidence-based practice in service provision.
The learning outcomes of this module will be achieved by a variety of methods including:
Experiential learning in the workplace, independent learning, independent analysis and identification of learning needs related to continuing professional development, independent review of materials available for eLearning, structured reading, problem-based learning and group discussion on study days.
1. A first degree, in pharmacy and registration as a pharmacist with the General Pharmaceutical Council (GPhC).
2. Candidates must be working (employed or self-employed) within an organisation providing pharmacy services whilst enrolled on the course.
3. Candidates must have access to patient’s health related data.
4. Normally the candidate will have a work-based tutor in their workplace.
5. Normally the candidate should be employed (including self-employed) in their practice role for at least 15 hours per week.
Knowledge and Understanding
1. Demonstrate a systematic understanding of common cancers and approach to screening, diagnosis and management based on individualised patient's prognosis including therapies for short and long-term management.
2. Demonstrate a systematic understanding of the use of evidence-based approach to medicines optimisation including management of side effects associated with treatment and supportive medication commonly used in oncology patients.
3. Demonstrate a systematic understanding of policies, pathways, services and resources applicable to patients and families to support adequate provision of care across the care systems.
Intellectual, Practical and Transferable Skills
1. Evaluate and make evidence-based patient care decisions at different stages of service provision including pre-detection and post diagnosis of cancer.
2. Demonstrate the ability to identify and evaluate patient and systems challenges related to the provision of pharmaceutical care for cancer patients and implement strategies to address them in line with evidence-based practice principles and relevant guidelines.
3. Demonstrate adaptability to relevant contexts in dealing with cancer patients, families and service providers to support partnership approaches to care provision.
£865.00
The price quoted above is per 15 credits and relates to students assessed as UK/home self-funded for fee purposes. Prices may differ for students that are assessed as EU Overseas. Fees status will normally stay with the student for the remainder of their course. Here you can find further details along with, costs and when your fees need to be paid. You may be able to obtain a Post Graduate student loan, for which you must sign up for the whole MSc programme and not just individual modules or a Post Graduate Diploma, further details can be found at Gov.uk Master’s Loan